================================================================================

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

(Mark  One)
[  X  ]  Quarterly  Report  Pursuant  to  Section  13 or 15(d) of the Securities
Exchange  Act  of  1934

For  the  quarterly  period  ended  June  30,  2002

Transition Report Pursuant to 13 or 15(d) of the Securities Exchange Act of 1934

For  the  transition  period  from  __________  to  __________

Commission  file  number:     333-85460

                          VIBRANT HEALTH INTERNATIONAL
        (EXACT NAME OF SMALL BUSINESS ISSUER AS SPECIFIED IN ITS CHARTER)

                   Nevada                          84-1595734
    (State  or  other  jurisdiction  of         (I.R.S.  Employer
     incorporation  of  organization)           Identification  No.)

        8907 E. Chenango Ave, Greenwood Village, CO       80111
         (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)       (ZIP CODE)

                     Issuer's telephone number: 303-713-1870

              (Former Name, Former Address and Former Fiscal Year,
                          If Changed Since Last Report)

Check  whether  the issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that the registrant was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past 90 days. Yes  X   No ___
                                                                     ---

As  of  August  15,  2002,  the  registrant had 3,935,000 shares of common stock
outstanding.

Transitional  Small  Business  Disclosure  Format  (Check  one):  Yes___ No  X
                                                                           ----
===============================================================================


<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

PART  I.  FINANCIAL  INFORMATION
ITEM  1.  FINANCIAL  STATEMENTS

<TABLE>
<CAPTION>

                           CONSOLIDATED BALANCE SHEET


                                                           June 30,     December 31, 2001
                                                             2002
                                                         ------------
                                                         (unaudited)
<S>                                                      <C>           <C>

                                     ASSETS
Current assets
 Cash . . . . . . . . . . . . . . . . . . . . . . . . .  $     4,539   $           23,009
                                                         ------------  -------------------

Total assets. . . . . . . . . . . . . . . . . . . . . .  $     4,539   $           23,009
                                                         ============  ===================

                      LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
 Accounts payable and accrued expenses. . . . . . . . .  $     3,291   $            1,064
 Note payable . . . . . . . . . . . . . . . . . . . . .       25,000               25,000
 Notes payable- related party . . . . . . . . . . . . .       15,000               15,000
                                                         ------------  -------------------
   Total current liabilities. . . . . . . . . . . . . .       43,291               41,064
                                                         ------------  -------------------

Commitments

Stockholders' deficit
 Common stock, authorized 100,000,000 shares, $.001 par        3,935                3,935
 value; 3,935,000 shares issued and outstanding
 Additional paid-in capital . . . . . . . . . . . . . .        4,035                4,035
 Deficit accumulated during the development stage . . .      (46,722)             (26,025)
                                                         ------------  -------------------
   Total stockholders' deficit. . . . . . . . . . . . .      (38,752)             (18,055)
                                                         ------------  -------------------

Total liabilities and stockholders' deficit . . . . . .  $     4,539   $           23,009
                                                         ============  ===================
</TABLE>


                                        2
<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

                               CONSOLIDATED STATEMENTS OF OPERATIONS


                                                                                                 For the Period
                                                                                                      from
                                                                                                  December 3,
                                                                                                      1997
                                                                                                  (Inception)
                                         For the Three Months Ended   For the Six Months Ended      through
                                         --------------------------  --------------------------
                                         June 30,2002  June 30,2001  June 30,2002  June 30,2001   June 30,2002
                                         ------------  ------------  ------------  ------------  --------------
                                         (unaudited)   (unaudited)   (unaudited)   (unaudited)   (unaudited)

<S>                                      <C>           <C>           <C>           <C>           <C>
Sales . . . . . . . . . . . . . . . . .  $     3,813   $         -   $     3,813   $         -   $     4,142

Cost of goods sold. . . . . . . . . . .        1,360             -         1,360             -         1,413
                                         ------------  ------------  ------------  ------------  ------------

Gross profit. . . . . . . . . . . . . .        2,453             -         2,453             -         2,729
                                         ------------  ------------  ------------  ------------  ------------

Operating expenses
    Website development costs . . . . .        2,209             -         2,209             -        12,209
    General and administrative expenses       10,581            18        18,141            36        33,484
                                         ------------  ------------  ------------  ------------  ------------
       Total operating expenses . . . .       12,790            18        20,350            36        45,693
                                         ------------  ------------  ------------  ------------  ------------

Loss from operations. . . . . . . . . .      (10,337)          (18)      (17,897)          (36)      (42,964)

Interest expense. . . . . . . . . . . .          900             -         2,800             -         3,758
                                         ------------  ------------  ------------  ------------  ------------

Net loss. . . . . . . . . . . . . . . .  $   (11,237)  $       (18)  $   (20,697)  $       (36)  $   (46,722)
                                         ============  ============  ============  ============  ============

Earnings (loss) per share - . . . . . .  $     (0.00)  $     (0.00)  $     (0.01)  $     (0.00)
                                         ============  ============  ============  ============
 basic and diluted

Weighted average shares outstanding . .    3,935,000     2,910,000     3,935,000     2,910,000
                                         ============  ============  ============  ============
</TABLE>


                                        3
<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

                      CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT
          FOR THE PERIOD FROM DECEMBER 3, 1997 (INCEPTION) THROUGH JUNE 30, 2002


                                                                        Deficit
                                                                        Accumulated
                                                            Additional  During the    Total
                                           Common Stock     Paid-In     Development   Stockholders'
                                        -----------------
                                         Shares    Amount   Capital     Stage         Equity
                                        ---------  -------  ----------  ------------  ---------
<S>                                     <C>        <C>      <C>         <C>           <C>

Balance - December 3, 1997 (Inception)          -  $     -  $      -    $      -      $   -

Stock issued . . . . . . . . . . . . .    970,000      970         -           -        970

Net loss for periods . . . . . . . . .          -        -         -        (691)      (691)
                                        ---------  -------  --------    ---------  ---------

Balance - December 31, 1999. . . . . .    970,000      970         -        (691)       279

Net loss . . . . . . . . . . . . . . .          -        -         -        (206)      (206)
                                        ---------  -------  --------    ---------  ---------

Balance - December 31, 2000. . . . . .    970,000      970         -        (897)        73

Stock issued . . . . . . . . . . . . .  2,965,000    2,965     4,035           -      7,000

Net loss . . . . . . . . . . . . . . .          -        -         -     (25,128)   (25,128)
                                        ---------  -------  --------    ---------  ---------

Balance - December 31, 2001. . . . . .  3,935,000    3,935     4,035     (26,025)   (18,055)

Net loss (unaudited) . . . . . . . . .          -        -         -     (20,697)   (20,697)
                                        ---------  -------  --------    ---------  ---------

Balance - June 30, 2002. . . . . . . .  3,935,000  $ 3,935  $  4,035    $(46,722)  $(38,752)
                                        =========  =======  ========    =========  =========
</TABLE>


                                        4
<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

                              CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                                                      Cumulative
                                                                                    from December
                                                                                       3, 1997
                                                      For the Six Months Ended      (Inception) to
                                                  --------------------------------
                                                   June 30, 2002    June 30, 2001    June 30, 2002
                                                  ---------------  ---------------  ---------------
                                                    (unaudited)      (unaudited)      (unaudited)
<S>                                               <C>              <C>              <C>
Cash flows from operating activities
 Net loss. . . . . . . . . . . . . . . . . . . .  $      (20,697)  $          (36)  $      (46,722)
   Adjustments to reconcile net loss to net cash
 used in operating activities
   Common stock issued for interest expense. . .               -                -              750
     Changes in operating assets and liabilities
    Accounts payable and accrued expenses. . . .           2,227                -            3,291
                                                  ---------------  ---------------  ---------------
       Net cash used by operating activities . .         (18,470)             (36)         (42,681)
                                                  ---------------  ---------------  ---------------

Cash flows from financing activities
 Proceeds from note payable. . . . . . . . . . .               -                -           25,000
 Proceeds from notes payable - related party . .               -                -           15,000
 Proceeds from issuance of common stock. . . . .               -                -            7,220
                                                  ---------------  ---------------  ---------------
       Net cash provided by financing activities               -                -           47,220
                                                  ---------------  ---------------  ---------------

Net (decrease) increase in cash. . . . . . . . .         (18,470)             (36)           4,539

Cash, beginning of year. . . . . . . . . . . . .          23,009               73                -
                                                  ---------------  ---------------  ---------------

Cash, end of period. . . . . . . . . . . . . . .  $        4,539   $           37   $        4,539
                                                  ===============  ===============  ===============
</TABLE>


                                        5
<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS


NOTE  1  -  ORGANIZATION  AND  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES
-----------------------------------------------------------------------------

Vibrant  Health  International  (the  Company),  was formed on July 9, 2001 as a
Nevada  company.  The Company's business operations and contracts will primarily
be  conducted  by  its  wholly  owned  subsidiary,  Vibrant  Health,  Inc.

Vibrant  Health,  Inc.  was  formed  on  December 3, 1997 as a Colorado company.
Vibrant  Health,  Inc.  intends  to  be a supplier and distributor of health and
nutritional products via use of the internet. Operations since inception consist
principally  of  setting  up  the  Company and developing the Company's website.

On July 9, 2001, the Company issued 2,910,000 shares of common stock in exchange
for  100%  of  the  outstanding shares of Vibrant Health, Inc. Due to the common
ownership  of  the  companies,  the  acquisition  was  accounted  for  as  a
recapitalization  of  Vibrant  Health,  Inc.


NOTE  2  -  LIQUIDITY  AND  MANAGEMENT'S  PLANS
-----------------------------------------------

The  Company  has  incurred accumulated losses of approximately $47,000 from the
inception  of  Vibrant  Health International through June 30, 2002. These losses
and  the significant future cash requirements related to developing the business
indicate  substantial  doubt that the Company may be able to continue as a going
concern  unless  additional  capital is obtained or future profitable operations
are  achieved.  Management  feels  that  if  a minimum of $87,500 of proceeds is
received  from  the  registration of its common stock on Form SB-2, Registration
Statement  under  the  Securities  Act of 1933, then the Company will be able to
maintain  its  operations  through December 31, 2002. There is no assurance that
management  will  be  successful  in  obtaining  such  financing.  The Company's
registration  went effective on August 5, 2002 and the Company is in the process
of  preparing the initial public offering.  The Company's offering will apply to
residents  of  California  and  Colorado.


                                        6
<PAGE>

ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS
-------------------------------------------------

GENERAL

     We  were  incorporated  in Nevada on July 9, 2001.  We are a distributor of
health  and  nutritional products.  We have commenced only limited operations as
of  the date of this filing.  Currently, we are distributing healthcare products
to our customers via orders generated on our newly functional Internet websites,
www.vibranthealthonline.com  and  www.store.yahoo.com/vibranthealthonline.  Our
---------------------------
current  business  operations  and  related  operational  contracts  are  being
conducted  out  of our wholly owned subsidiary, Vibrant Health, Inc., a Colorado
corporation.

     We  intend  to  distribute  health  and  nutritional  products.  We  are  a
distribution  company  and  do  not have any expertise in nutritional science or
manufacturing.  The  name  Vibrant  Health does not reflect health expertise but
rather  is  marketing  oriented  and  was selected to instill in our customers a
feeling  of  vigor,  energy, and motivation, with the obvious clarifying word of
health  pinpointing  our  product  focus.  We believe that individuals with such
feelings  will  understand  the value of fitness and appreciate the value of our
products.

     We  intend  to focus our marketing efforts in generating sales orders using
our  Internet  websites. We will accept ancillary orders when they are available
to  us  by facsimile, email, phone calls, or mail. However, our printed material
will generally advocate and guide the potential customer to route orders for our
product  via our websites. Although our websites are operational, we believe our
websites  will  continuously  be updated and refined and therefore do not have a
specific  completion  dates.

     We do not manufacture the products that we sell.  Instead, we contract with
health and nutritional product formulators who specialize in supplying products.
We  do not generally inventory or ship product from our offices.  Our plan is to
out-source  our order fulfillment operations so that we can focus on the sale of
our  products.

     We  have  entered into a five year agreement that expires October 2006 with
Imagenetix,  Inc.  a  company  located in southern California, to supply us with
their  proprietary  products.  They  have  experience in packaging and supplying
health  and  nutritional  products. They will assist us in choosing a few select
products  of  theirs which they believe are their highest quality products, with
large  potential  markets,  and  with  profit  margins  that  would  warrant our
attention.

     We  selected Imagenetix, Inc. because they are established in the nutrition
and  natural  health  products  area.  If  we  were  to lose this agreement with
Imagenetix, Inc., our ability to obtain a supply of quality product on favorable
terms  would  probably  be greatly hampered. We believe that we would be able to
find  other  suppliers,  but  that  they  would require a greater expenditure of
management  time  and  that  profit  margins  on  sales  may  decrease.

     Our  websites  currently  list  two  products  for  sale. Each is a form of
Imagenetix's  proprietary product, Celadrin(TM). We market a cream form in a jar
and  an  oral gelcap form of this product. We place a label on each product sold
identifying the products as either Vibrant Creme or Vibrant Celcaps as well as a
label  identifying  the  product  as  Celadrin(TM).  We have no exclusivity with
respect  to  any of these products. In fact, there are several distributors that
market  other  private  label  forms  of  these products through their marketing
organizations.  We  are  the  first  E-commerce  company  which  will distribute
Celadrin(TM).  We are unaware of any other companies that are currently offering
Celadrin(TM)  products  online.

     Celadrin(TM)  is  a  scientifically tested and effective formulated product
developed  to  provide  support  for  healthy  joint  function  and  mobility.
Celadrin(TM)  consists  of a complex of scientifically targeted fatty acids. The
oral  form  of  Celadrin(TM) was subjected to clinical studies, with exceptional
result  for efficacy as well as absence of side effects. We intend to capitalize
on  what  we  believe  will  be  a  surge  of  demand  for these products as new
information  is  released  on  Celadrin(TM)  in  the  near  future.


                                        7
<PAGE>

     We  are  supplying  products  under  our  own  Vibrant  Health  brand name.
Imbedding the Vibrant Health name as part of the product title may significantly
increase  the name recognition of both product and Company and associate it with
quality  and  value.  Costs  associated with labeling products with our name are
minimal  and  consist  of  printing  new  labels  for  product  containers.

THREE  MONTH  PERIODS  ENDED  JUNE  30,  2002  AND  2001

     The  Company  had  $3,813 in sales from continuing operations for the three
month  period  ended  June  30,  2002 and sales of $-0- for the same three month
period in 2001. Sales were higher in the quarter ended June 30, 2002 because the
Company commenced operations in July 2001. Cost of goods sold was $1,360 for the
period  ended  June  30,  2002 compared to $-0- for the same period in 2001. The
Company  had  a  gross profit of $2,453 for the three months ended June 30, 2002
compared  to  $-0-  for  the  same  period  in  2001.

     Operating  expenses  for  the  three month periods ended June 30, 2002 were
$12,790  compared  to  $18  for  the  same period in 2001. Expenses consisted of
general  corporate  administration,  legal  and  professional  expenses,  and
accounting and auditing costs and wages. Increased expenses for the period ended
June  30,  2002  were  primarily  due to website development costs and the costs
associated  with  our  initial  registration statement. The Company has interest
expense  of  $900  for the three months ended June 30, 2002 compared to $-0- for
the  same  period  in  2001.

     As  a  result  of the foregoing factors, the Company realized a net loss of
$11,237  for the three months ended June 30, 2002 as compared to net loss of $18
for  the  same  period  in  2001.

SIX  MONTH  PERIODS  ENDED  JUNE  30,  2002  AND  2001

     The  Company  had  $3,813  in  sales from continuing operations for the six
month period ended June 30, 2002 and sales of $-0- for the same six month period
in  2001.  Sales  were  higher  in  the  quarter ended June 30, 2002 because the
Company commenced operations in July 2001. Cost of goods sold was $1,360 for the
six  month  period  ended  June 30, 2002 compared to $-0- for the same period in
2001. The Company had a gross profit of $2,453 for the six months ended June 30,
2002  compared  to  $-0-  for  the  same  period  in  2001.

     Operating  expenses  for  the  six  month  period  ended June 30, 2002 were
$20,350  compared  to  $36  for  the  same period in 2001. Expenses consisted of
general  corporate  administration,  legal  and  professional  expenses,  and
accounting and auditing costs and wages. Increased expenses for the period ended
June  30,  2002  were  primarily  due to website development costs and the costs
associated  with  our  initial  registration statement. The Company has interest
expense  of  $2,800  for the six months ended June 30, 2002 compared to $-0- for
the  same  period  in  2001.

     As  a  result  of the foregoing factors, the Company realized a net loss of
$20,697  for  the  six months ended June 30, 2002 as compared to net loss of $36
for  the  same  period  in  2001.

LIQUIDITY  AND  CAPITAL  RESOURCES

     At  June 30, 2002 the Company had assets consisting of $4,539 cash on hand.
Current  liabilities  consisted  of  accounts  payable  and  accrued expenses of
$3,291,  a  note  payable  of  $25,000  and notes payable to a related party for
$15,000  for total current liabilities of $43,291. The Company does not have any
long  term  capital  commitments.


                                        8
<PAGE>

     The  Company  believes that its current cash needs can be met with the cash
on  hand  and  from the proceeds of its initial public offering. However, should
the  Company find it necessary to raise additional capital, the Company may sell
common  stock  of  the  Company  or  enter  into  debt  financing  agreements.

FORWARD-LOOKING  STATEMENTS

     Certain  information  included  in  this  report  contains  forward-looking
statements made pursuant to the Private Securities Litigation Reform Act of 1995
("Reform  Act"). Such statements are based on current expectations and involve a
number  of known and unknown risks and uncertainties that could cause the actual
results  and  performance  of the Company to differ materially from any expected
future  results  or  performance,  expressed  or implied, by the forward-looking
statements. In connection with the safe harbor provisions of the reform act, the
Company  has  identified  important  factors  that could cause actual results to
differ  materially  from  such  expectations,  including  operating uncertainty,
acquisition  uncertainty,  uncertainties  relating  to  economic  and  political
conditions  and  uncertainties  regarding  the impact of regulations, changes in
government policy and competition. Reference is made to all of the Company's SEC
filings,  including  the  Company's Report on Form 10KSB, incorporated herein by
reference,  for  a  description  of certain risk factors. The Company assumes no
responsibility  to  update  forward-looking  information  contained  herein.

PART  II:  OTHER  INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS

     The  Company is not a party defendant in any material pending or threatened
litigation  and  to  its  knowledge,  no  action,  suit  or proceedings has been
threatened  against  its  officers  and  its  directors.

ITEM  2.  CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS

     On  July  9,  2001,  we issued 100,000 shares to our founder and President,
Thomas  H.  McAdam in exchange for $1,000 cash and we issued 2,109,000 shares in
exchange  for  703,000  shares  of  Vibrant  Health, Inc., and we issued 750,000
shares  for  consideration of making a loan of $15,000 accessible by the Company
which  was  valued  at  $750.  The securities were sold in private transactions,
without  registration  in  reliance on the exemption provided by Section 4(2) of
the  Securities  Act.  The  investor  had  access  to  all  material information
pertaining  to  the  Company and its financial condition. The investor completed
and  signed  a  subscription  agreement  attesting  to  his  sophistication  or
accredited  investor status and investment intent. No broker was involved and no
commissions  were  paid  in  the  transactions.

     On  July 9, 2001, we issued 801,000 shares to a shareholder in exchange for
their  267,000  shares of Vibrant Health, Inc. The stock was valued at $801. The
securities  were  sold in private transactions, without registration in reliance
on  the  exemption provided by Section 4(2) of the Securities Act. Each investor
had  access  to  all  material  information  pertaining  to  the Company and its
financial condition. Each investor completed and signed a subscription agreement
attesting  to  his  sophistication  or accredited investor status and investment
intent. No broker was involved and no commissions were paid in the transactions.

     Mr.  Thomas  McAdam thereafter purchased 550,000 shares of the newly issued
stock  from  one  of those shareholders in a private transaction, thus, bringing
Mr.  Thomas  McAdam's total ownership to 3,509,000 shares and reducing the other
two  shareholders' total to a combined 251,000 shares. The shares were purchased
for  $550.00  on  August  27,  2001.

     In  September,  2001,  we  issued  175,000  shares  of  common stock to two
accredited  investors for a total of $5,250. The securities were sold in private
transactions,  without  registration  in  reliance  on the exemption provided by
Section  4(2)  of  the  Securities Act. Each investor had access to all material
information pertaining to the Company and its financial condition. Each investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions  were  paid  in  the  transactions.


                                        9
<PAGE>

     The  Company filed an SB-2 Registration Statement on its common stock for a
minimum  of  $87,500  and a maximum of $200,000 with the Securities and Exchange
Commission  that  went  effective  on  August 2, 2002. The Company is offering a
minimum  of  350,000  shares and a maximum of 800,000 shares at $0.25 per share.
The  Commission  file  number  is 333-85460. The offering commenced on August 2,
2002, however the Company has not yet raised the minimum amount and has in place
an  escrow  agreement  whereby  all funds are placed in escrow until the minimum
amount  is  raised.  Should  the Company fail to raise the minimum, all proceeds
will  be  refunded.

     As  of  August 21, 2002, the Company has incurred expenses in the amount of
approximately  $17,000  relating to the Registration Statement. Expenses include
legal  fees,  accounting  fees,  escrow fees, filing fees, printing and transfer
agent  costs.  There are no underwriters discounts, commissions or finders fees.
The  Company originally estimated expenses to be $20,000 and believes this is an
accurate  estimate.

ITEM  3.  DEFAULTS  UPON  SENIOR  SECURITIES

None.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  VOTE  OF  SECURITY  HOLDERS

None.

ITEM  5.  OTHER  INFORMATION

None.

ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

(a)     Exhibit                                   Description

        99.1                       Certification  of the Chief Executive Officer
                                   of  Vibrant  Health International pursuant to
                                   18  U.S.C.  Section 1350, as adopted pursuant
                                   to  Section  906 of the Sarbanes-Oxley Act of
                                   2002

         99.2                      Certification  of the Chief Financial Officer
                                   of  Vibrant  Health International pursuant to
                                   18  U.S.C.  Section 1350, as adopted pursuant
                                   to  Section  906 of the Sarbanes-Oxley Act of
                                   2002

(b)     Reports  on  Form  8-K

     No  reports  were filed on Form 8-K during the quarter ended June 30, 2002.


                                       10
<PAGE>

SIGNATURES


     Pursuant  to  the requirements of the Securities Exchange Act of 1934, this
Form  10-QSB  Report, for the Quarter ended June 30, 2002, has been signed below
by  the  following person on behalf of the Registrant and in the capacity and on
the  date  indicated.

August  28,  2002


VIBRANT  HEALTH  INTERNATIONAL



     By     /s/ Thomas  H.  McAdam
            ------------------------
            Thomas  H.  McAdam
            Chief  Executive  Officer  and
            Chief  Financial  Officer


                                       11
<PAGE>